Clinical Trial Update: Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluating gemcitabine and carboplatin followed by paclitaxel in patients with stage III or stage IV non-small cell lung cancer has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Paraplatin (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED